DIA/FDA Biosimilars Conference

August 24, 2012 12:17 PM

DIA, in collaboration with FDA, is organizing a biosimilars conference in Washington DC, on September 12-13, 2012.

The Biologics Price Competition and Innovation Act (BPCI Act) of 2009 was enacted as part of the Affordable Care Act. This conference will deal with the scientific and regulatory issues related to the demonstration of biosimilarity, focusing both on the FDA’s current thinking on approaches to biosimilar development as well as perspectives of other regulators. In the conference, the FDA guidance will be discussed from the perspectives of regulators and industry.

If you would like to attend the conference, you can get more information from here.

Would you like to post an event on Biosimilar News?

 

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!